PHINIA INC.·4

Mar 24, 5:05 PM ET

Newton Latondra 4

Research Summary

AI-generated summary

Updated

PHINIA Director Newton Latondra Receives 16-Share Award

What Happened
Newton Latondra, a director of PHINIA Inc. (PHIN), received a grant of 16 deferred restricted stock units (DRSUs) on 2026-03-20. The reported acquisition price is $0.00, indicating an award/grant rather than a purchase. These 16 DRSUs are derivative awards that represent the economic equivalent of 16 shares of PHINIA common stock and will convert to shares under the issuer's plan terms.

Key Details

  • Transaction date: 2026-03-20; Form 4 filed 2026-03-24 (within the two business-day filing window).
  • Transaction type/code: A — Grant/Award of derivative securities (DRSUs).
  • Amount: 16 DRSUs; reported price $0.00 (no cash exchanged).
  • Shares owned after transaction: Not specified in the provided filing details.
  • Footnotes:
    • F1: Each DRSU equals one share economically and vests on the one-year anniversary of the grant; DRSUs settle into shares (including any dividend-equivalent DRSUs) upon the reporting person's termination of board service under the Director Deferred Compensation Program and 2023 Stock Incentive Plan.
    • F2: Some DRSUs can reflect automatic reinvestment of dividend equivalents on outstanding DRSUs held on the dividend record date.

Context
This was an equity award (not a market purchase or sale). DRSUs are derivative awards that typically do not result in immediate share ownership or sale proceeds; they convert to actual shares per the plan’s vesting/settlement rules and may affect long-term alignment with shareholders. The $0.00 price and footnotes indicate standard director compensation and dividend reinvestment mechanics rather than a cash investment or disposition.